International Journal of Homoeopathic Sciences

Eczema, or atopic dermatitis, is a chronic, relapsing inflammatory skin disorder and the most common form of dermatitis. It typically begins in early childhood and persists throughout life, significantly affecting physical, psychological, and social well-being. A single-arm, prospective observational pilot study was conducted to assess the effectiveness and feasibility of individualised homoeopathic treatment in improving the quality of life of patients with Dermatitis. DLQI and EASI scores were recorded before and after treatment. Five out of eight enrolled participants completed the study and were included in the final analysis. Statistical evaluation was performed using paired t-tests. The mean DLQI score reduced from 25.6 to 23.2, showing modest improvement but without statistical significance (p = 0.108). In contrast, the EASI score decreased from 29.6 to 24.4 (p = 0.0029), indicating meaningful clinical improvement in eczema severity. Individualised homoeopathic treatment demonstrated potential benefits in reducing eczema severity and improving quality of life. These findings support homoeopathy as a complementary therapeutic approach and warrant larger, controlled clinical trials to validate outcomes.